Federal Minister of Health, Akilah Byron-Nisbett.

Her comment is also in keeping with the fact that the current batch of Astra Zeneca vaccines SKN has are due to expire by month’s end.

The Johnson & Johnson Covid-19 vaccine, is among the group of vaccines to have been given the green light for emergency approval, by the World Health Organization (WHO).

Other vaccines include: Pfizer-BioNTech, AstraZeneca, Moderna, among others.

In terms of its efficacy, who.int says 28 days after inoculation, there is an efficacy rate of 85.4% against hospitalization from the Covid-19 virus.

However, a dose of the Johnson & Johnson was found in clinical trials to have an efficacy of 66.9% against symptomatic moderate and severe Covid-19 infection.

But how does this vaccine, compare to the dual dose vaccines already in use?

According to the WHO, all of the vaccines (including Johnson & Johnson) that have achieved WHO Emergency Use Listing are highly effective in preventing severe disease and hospitalization, due to COVID-19.